
|Articles|October 10, 2012
Two-drug combination best for melanoma
A two-drug combination for metastatic melanoma reduced the odds of progression by 60 percent, demonstrating more effectiveness than monotherapy, according to researchers.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Social Media Mythbusters: Skin Cycling
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














